Carb claims rulemaking
This article was originally published in The Tan Sheet
A proposed rule defining carbohydrate nutrient content claims and an advanced notice of proposed rulemaking requesting public comments on data and information on "carbohydrate-related label claims and consumer understanding and behaviors related to such claims" is expected to publish "this fiscal year," according to FDA Deputy Commissioner Medical & Scientific Affairs Scott Gottlieb, MD. The upcoming publication was announced during a speech delivered at the Grocery Manufacturers of America's "Convention on the Future of Food" Nov. 30. FDA requested approval from the Office of Management & Budget to conduct a study on consumer perception of carbohydrate label claims in August (1"The Tan Sheet" Aug. 22, 2005, p. 9)...
You may also be interested in...
FDA is seeking clearance from the Office of Management & Budget to conduct a study that would "help enhance FDA's understanding of consumer response to carbohydrate content claims on food labels.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.